Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroprotection impact of biochanin A against pentylenetetrazol-kindled mice: Targeting NLRP3 inflammasome/TXNIP pathway and autophagy modulation
Rehab M. El‐Sayed, Mohamed N. Fawzy, Hala F. Zaki, et al.
International Immunopharmacology (2023) Vol. 115, pp. 109711-109711
Closed Access | Times Cited: 20

Showing 20 citing articles:

Mechanism of NLRP3 Inflammasome in Epilepsy and Related Therapeutic Agents
Juan Chen, Yuan Gao, Ning Liu, et al.
Neuroscience (2024) Vol. 546, pp. 157-177
Closed Access | Times Cited: 5
Berberine ameliorates seizure activity and cardiac dysfunction in pentylenetetrazol-kindling seizures in rats: Modulation of sigma1 receptor, Akt/eNOS signaling, and ferroptosis
Shrouk M Basiouny, Hala F. Zaki, Shimaa M. Elshazly, et al.
Neuropharmacology (2025), pp. 110295-110295
Closed Access
HMGB1: Different secretion pathways with pivotal role in epilepsy and major depressive disorder
Mustafa M Shokr, Reem M Eladawy
Neuroscience (2025)
Closed Access
Mitigating seizure-induced cognitive deficits in mice induced with pentylenetetrazol by roflumilast through targeting the NLRP3 inflammasome/BDNF/SIRT3 pathway and regulating ferroptosis
Mohamed N. Fawzy, Enas A. Abd El‐Haleim, Hala F. Zaki, et al.
Life Sciences (2025), pp. 123488-123488
Closed Access
Biochanin A Mitigates Pressure Overload-Induced Cardiac Hypertrophy Through Modulation of the NF-κB/Cbl-b/NLRP3 Signaling Axis
Lina Ba, Nan Wu, Xiang Feng, et al.
Cardiovascular Drugs and Therapy (2025)
Closed Access
Insights into therapeutic approaches for the treatment of neurodegenerative diseases targeting metabolic syndrome
Komal Thapa, Heena Khan, Samrat Chahuan, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
The NLRP3 Inflammasome in Neurodegenerative Disorders: Insights from Epileptic Models
Laura Palumbo, Marianna Carinci, Annunziata Guarino, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2825-2825
Open Access | Times Cited: 13
Biochanin a ameliorates DSS-induced ulcerative colitis by improving colonic barrier function and protects against the development of spontaneous colitis in the Muc2 deficient mice
Haina Zhang, Xueqi Wang, Linxian Zhao, et al.
Chemico-Biological Interactions (2024) Vol. 395, pp. 111014-111014
Closed Access | Times Cited: 3
An explanation of the role of pyroptosis playing in epilepsy
Xuefei Zhang, Ting Zhao, Songxue Su, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112386-112386
Closed Access | Times Cited: 3
Neuroprotective potential of biochanin-A and review of the molecular mechanisms involved
Lovedeep Singh, Navneet Kaur, Rajbir Bhatti
Molecular Biology Reports (2023) Vol. 50, Iss. 6, pp. 5369-5378
Closed Access | Times Cited: 9
Astragalus polysaccharides ameliorate epileptogenesis, cognitive impairment, and neuroinflammation in a pentylenetetrazole-induced kindling mouse model
Yuling Lu, Minglin Lin, Sijie Ou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Computational and Experimental Approaches Exploring the Role of Hesperetin in Improving Autophagy in Rat Diabetic Retinopathy
Reem Alshaman, Eman Kolieb, Rehab M. El‐Sayed, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 552-552
Open Access | Times Cited: 2
Biochanin A mitigates ulcerative colitis and intestinal inflammation in mice by inhibiting MAPK/NF‐kB (p65) axis
Uttam Kulhari, Ashitha Rajanan, Anju Ambujakshan, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 6
Closed Access | Times Cited: 1
Harnessing Therapeutic Potentials of Biochanin A in Neurological Disorders: Pharmacokinetic and Pharmacodynamic Overview
Ankit Kumar, Efthalia Angelopoulou, Efstratios‐Stylianos Pyrgelis, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 8
Closed Access | Times Cited: 1
An overview on the potential application of nanotechnology in enhancing the therapeutic efficacy of phytoestrogens
Aroma Joshi, Deepika Kathuria, Maman Paul, et al.
Food Chemistry (2024) Vol. 464, pp. 141779-141779
Closed Access | Times Cited: 1
Biochanin A inhibits cardiac hypertrophy and fibrosis in vivo and in vitro
Zhenyu Feng, Ningning Zhang, Jie Bai, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116002-116002
Open Access | Times Cited: 4
Quetiapine attenuates cadmium neurotoxicity by suppressing oxidative stress, inflammation, and pyroptosis
Hanan S. Althagafy, Steve Harakeh, Sheren A. Azhari, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access
Metabolomic Profiling and In Vivo Antiepileptic Effect of Zygophyllum album Aerial Parts and Roots Crude Extracts against Pentylenetetrazole-Induced Kindling in Mice
Asmaa R. Abdel-Hamed, Alaa S. Wahba, Dina M. Khodeer, et al.
Metabolites (2024) Vol. 14, Iss. 6, pp. 316-316
Open Access
Biochanin A restored the blood–brain barrier in cerebral ischemia-reperfusion in rats
Abdulmutalip Karaaslanlı, Fırat Aşır, Görkem Tutal Gürsoy, et al.
Revista da Associação Médica Brasileira (2024) Vol. 70, Iss. 6
Open Access
Statins for vascular dementia: A hype or hope
Haroon Raja, Hayder M. Al‐kuraishy, Mustafa M Shokr, et al.
Neuroscience (2024) Vol. 567, pp. 45-55
Open Access
Page 1

Scroll to top